Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (221-230 of 421) with videos related to

Pageof 43
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 18, 2019
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysisAng Li, Nicole M Kuderer, David A Garcia, et al.
Thrombosis Research|May 23, 2024
Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolismLaura Girardi, Leonardo Augusto Ciuffini, Vicky Mai, et al.
American Journal of Surgery|January 1, 2019
Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgeryMarc Carrier, Alon D Altman, Normand Blais, et al.
Plos One|July 16, 2025
Impact of clonal hematopoiesis of indeterminate potential on arterial atherothrombosis and venous thromboembolism: Protocol for a systematic review and meta-analysisAngela Todorovski, Tzu-Fei Wang, Evan Sterling, et al.
Thrombosis Research|April 15, 2026
Impact of concurrent antiplatelet use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trialMysa Saad, Tzu-Fei Wang, Ranjeeta Mallick, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta-analysisYan Xu, Daniel You, Halli Krzyzaniak, et al.
Thrombosis and Haemostasis|March 9, 2022
Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving ChemotherapyDanielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, et al.
Thrombosis Research|August 20, 2013
Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trialHabeeb Majeed, Marc Rodger, Melissa Forgie, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic reviewBethany R Samuelson Bannow, Agnes Y Y Lee, Alok A Khorana, et al.
Thrombosis Research|November 6, 2021
Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trialAmeeta L Nayak, Amin Zahrai, Ranjeeta Mallick, et al.
Pageof 43

Showing results (221-230 of 421) with videos related to

Sort By:
Pageof 43
Journal of Thrombosis and Haemostasis : JTH|August 18, 2019
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysisAng Li, Nicole M Kuderer, David A Garcia, et al.
Thrombosis Research|May 23, 2024
Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolismLaura Girardi, Leonardo Augusto Ciuffini, Vicky Mai, et al.
American Journal of Surgery|January 1, 2019
Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgeryMarc Carrier, Alon D Altman, Normand Blais, et al.
Plos One|July 16, 2025
Impact of clonal hematopoiesis of indeterminate potential on arterial atherothrombosis and venous thromboembolism: Protocol for a systematic review and meta-analysisAngela Todorovski, Tzu-Fei Wang, Evan Sterling, et al.
Thrombosis Research|April 15, 2026
Impact of concurrent antiplatelet use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trialMysa Saad, Tzu-Fei Wang, Ranjeeta Mallick, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta-analysisYan Xu, Daniel You, Halli Krzyzaniak, et al.
Thrombosis and Haemostasis|March 9, 2022
Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving ChemotherapyDanielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, et al.
Thrombosis Research|August 20, 2013
Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trialHabeeb Majeed, Marc Rodger, Melissa Forgie, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic reviewBethany R Samuelson Bannow, Agnes Y Y Lee, Alok A Khorana, et al.
Thrombosis Research|November 6, 2021
Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trialAmeeta L Nayak, Amin Zahrai, Ranjeeta Mallick, et al.
Pageof 43